Please login to the form below

Not currently logged in
Email:
Password:

Ebola

This page shows the latest Ebola news and features for those working in and with pharma, biotech and healthcare.

Merck claims first-ever okay for Ebola vaccine, in Europe

Merck claims first-ever okay for Ebola vaccine, in Europe

Comes shortly after J&J filed its Ebola candidate with EMA. Merck &Co/MSD has secured the first approval in Europe for a vaccine to protect against Ebola, getting a green ... The approval comes shortly after Johnson &Johnson  filed its Ebola vaccine

Latest news

  • J&J catches up to Merck, files Ebola vaccine in Europe J&J catches up to Merck, files Ebola vaccine in Europe

    Now, J&J is looking to catch up – it is seeking licensure for its own investigational Ebola vaccine regimen in Europe. ... Meanwhile, J&J and Merck are now looking to gain official regulatory approvals for their Ebola vaccines with global healthcare

  • Merck wins CHMP recommendation for Ebola vaccine Merck wins CHMP recommendation for Ebola vaccine

    Has also been granted priority review by FDA. Merck/MSD has been granted a positive opinion recommending the approval of its investigational V920 Ebola Zaire vaccine from the Committee for Medicinal ... More than 200, 000 people have been vaccinated

  • FDA starts speedy review of Merck’s Ebola vaccine FDA starts speedy review of Merck’s Ebola vaccine

    More than 200, 000 people have been vaccinated against Ebola in the country, either with V920 or another experimental vaccine from Johnson &Johnson. ... GlaxoSmithKline also had three Ebola vaccine candidates in development but out-licensed them to the

  • UK no longer measles-free as vaccination rates fall dramatically UK no longer measles-free as vaccination rates fall dramatically

    for health emergencies such as Ebola outbreaks, helping care for an ageing population and keeping people healthy from infections like flu,” said Sheuli Porkess, executive director at the ABPI.

  • Potential cure for Ebola following trial success Potential cure for Ebola following trial success

    Two treatments increased rates of survival. An independent monitoring board has called for the early termination of an Ebola trial, following findings that two out of four drugs being tested are ... Ebola in the DRC began in August 2018, with the

More from news
Approximately 26 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Amazing Africa Amazing Africa

    HIV/AIDS, malaria, famine, Ebola: there is a reason why the World Health Organization (WHO) considers it to be the region confronting the most dramatic public health crisis across the globe.

  • The world is our laboratory The world is our laboratory

    We are also dedicated to developing a vaccine for Ebola. We committed $200m to accelerate and significantly expand the production of our Ebola vaccine programme. ... test, manufacture and deploy the Ebola vaccine regimen.

  • Wearables: the tangible product of the patient revolution Wearables: the tangible product of the patient revolution

    The opportunity is massive - in the public health arena, there exists the possibility that outbreaks of diseases such as Ebola or influenza could be seen and stopped before they become critical.

  • Can patient-centricity work for pharma? Can patient-centricity work for pharma?

    More recently, firms such as GSK and Janssen have gained kudos by working with governments to create a new Ebola vaccine, even though the costs for this will likely not be

  • Communicating in a crisis Communicating in a crisis

    Timeline of Ebola outbreak in West Africa. December 2013. Two-year-old child contracts Ebola virus in Guinea. ... J&J announces it will fast-track vaccine research. October 2014. EMA offers orphan drug benefits to Ebola drugs.

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....
Early diagnosis underpins NHS cancer strategy
Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan...

Infographics